awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47140442-E17AB061-1085-478E-906A-1FAD26DCF3ED
Q47140442-E17AB061-1085-478E-906A-1FAD26DCF3ED
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47140442-E17AB061-1085-478E-906A-1FAD26DCF3ED
Ruxolitinib combined with vorinostat suppresses tumor growth and alters metabolic phenotype in hematological diseases.
P2860
Q47140442-E17AB061-1085-478E-906A-1FAD26DCF3ED
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47140442-E17AB061-1085-478E-906A-1FAD26DCF3ED
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9f872113878ccbf3d2e34e50baab714ff4b6e6b6
P2860
The PIM inhibitor AZD1208 synergizes with ruxolitinib to induce apoptosis of ruxolitinib sensitive and resistant JAK2-V617F-driven cells and inhibit colony formation of primary MPN cells.